The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis

BORA İ. E., Akdede B. B., ALPTEKİN K.

PSYCHOLOGICAL MEDICINE, cilt.47, sa.6, ss.1030-1040, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 47 Sayı: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1017/s0033291716003366
  • Dergi Adı: PSYCHOLOGICAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Sayfa Sayıları: ss.1030-1040
  • Anahtar Kelimeler: Cognition, diabetes mellitus, dyslipidemia, hypertension, metabolic syndrome, obesity, schizophrenia, CLINICAL ANTIPSYCHOTIC TRIALS, TYPE-2 DIABETES-MELLITUS, ULTRA-HIGH RISK, 1ST-EPISODE PSYCHOSIS, DEFICITS, OBESITY, HYPERTENSION, ASSOCIATION, PREVALENCE, NEUROCOGNITION
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background. Individuals with schizophrenia are at greater risk for metabolic syndrome (MetS) which is associated with cognitive deficits in the general population. MetS might be potentially an important contributing factor to cognitive impairment in schizophrenia.